BR0015610B8 - composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto - Google Patents

composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto

Info

Publication number
BR0015610B8
BR0015610B8 BRPI0015610A BR0015610A BR0015610B8 BR 0015610 B8 BR0015610 B8 BR 0015610B8 BR PI0015610 A BRPI0015610 A BR PI0015610A BR 0015610 A BR0015610 A BR 0015610A BR 0015610 B8 BR0015610 B8 BR 0015610B8
Authority
BR
Brazil
Prior art keywords
salts
stable
compound
diisopropylamino
phenylpropyl
Prior art date
Application number
BRPI0015610A
Other languages
English (en)
Other versions
BRPI0015610C1 (pt
BR0015610A (pt
BRPI0015610B1 (pt
Inventor
Meese Claus
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7929277&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0015610(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of BR0015610A publication Critical patent/BR0015610A/pt
Publication of BRPI0015610B1 publication Critical patent/BRPI0015610B1/pt
Publication of BR0015610B8 publication Critical patent/BR0015610B8/pt
Publication of BRPI0015610C1 publication Critical patent/BRPI0015610C1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C07C215/54—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/06—Anti-spasmodics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Luminescent Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Detergent Compositions (AREA)

Abstract

"sais estáveis de derivados de 3,3-difenil-propilamina". a presente invenção refere-se a compostos estáveis, cristalinos, altamente puros de derivados de 3,3-difenilpropilaminas sob a forma de seus sais, um processo para a fabricação de produtos intermediários estáveis, altamente puros. o processo é particularmente caracterizado por regio e quimiosseletividade e elevado rendimento. são proporcionados sais de monoésteres fenólicos de 3,3-difenilpropilaminas, que são particularmente bem adequados para utilização em formulações farmacêuticas. compostos preferidos são hidrogênio fumarato do éster r-(+)-diisobutirato de 2-(3-diisopropilamino-1-fenilpropil)-4-hidroximetilfenila e cloridrato do éster r-(+)-isobutirato de 2-(3-diisopropilamino-1-fenilpropil)-4-hidroximetilfenila. além do mais, são proporcionados produtos intermediários cristalinos, estáveis que são essenciais para a obtenção dos sais acima mencionados. um produto intermediário preferido é o éster metílico de ácido r-(-)-3-(3-diisopropilamino-fenilapropil)-4-hidróxi benzóico.
BRPI0015610A 1999-11-16 2000-11-15 composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto BRPI0015610C1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19955190A DE19955190A1 (de) 1999-11-16 1999-11-16 Stabile Salze neuartiger Derivate von 3,3-Diphenylpropylaminen
PCT/EP2000/011309 WO2001035957A1 (de) 1999-11-16 2000-11-15 Stabile salze neuartiger derivate von 3,3-diphenylpropylaminen

Publications (4)

Publication Number Publication Date
BR0015610A BR0015610A (pt) 2002-07-30
BRPI0015610B1 BRPI0015610B1 (pt) 2016-04-19
BR0015610B8 true BR0015610B8 (pt) 2017-10-31
BRPI0015610C1 BRPI0015610C1 (pt) 2021-05-25

Family

ID=7929277

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0015610A BRPI0015610C1 (pt) 1999-11-16 2000-11-15 composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto

Country Status (30)

Country Link
US (1) US6858650B1 (pt)
EP (3) EP1690536B1 (pt)
JP (6) JP4083431B2 (pt)
KR (2) KR100563149B1 (pt)
CN (1) CN1215045C (pt)
AT (3) ATE286872T1 (pt)
AU (1) AU778132B2 (pt)
BR (1) BRPI0015610C1 (pt)
CA (1) CA2389749C (pt)
CY (2) CY1106204T1 (pt)
CZ (2) CZ302967B6 (pt)
DE (5) DE29923134U1 (pt)
DK (3) DK1230209T3 (pt)
EA (1) EA005588B1 (pt)
ES (3) ES2270240T3 (pt)
GE (1) GEP20084430B (pt)
HK (3) HK1045148B (pt)
HU (2) HU228197B1 (pt)
IL (2) IL149567A0 (pt)
IS (2) IS2124B (pt)
MX (1) MXPA02004603A (pt)
NO (2) NO323920B1 (pt)
NZ (1) NZ519230A (pt)
PL (1) PL201422B1 (pt)
PT (3) PT1481964E (pt)
SI (3) SI1690536T1 (pt)
SK (3) SK287430B6 (pt)
UA (2) UA73324C2 (pt)
WO (1) WO2001035957A1 (pt)
ZA (1) ZA200203315B (pt)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) * 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) * 1999-11-16 2000-06-29 Sanol Arznei Schwarz Gmbh Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen
DE10028443C1 (de) * 2000-06-14 2002-05-29 Sanol Arznei Schwarz Gmbh Verfahren zur Herstellung von 3,3-Diarylpropylaminen, (R,S)- und (R)-4-Phenyl-2-chromanon-6-carbonsäure sowie (R)-4-Phenyl-2-chromanon-carbonsäure-cinchonidinsalz und deren Verwendung zur Herstellung eines rechtsdrehenden Hydroxybenzylalkohols und von pharmazeutischen Zusammensetzungen
DE10315878B4 (de) * 2003-04-08 2009-06-04 Schwarz Pharma Ag Vorrichtung zur transdermalen Verabreichung von Fesoterodin und Verwendung
DE10315917A1 (de) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Hochreine Basen von 3,3-Diphenylpropylaminmonoestern
WO2005012227A2 (en) * 2003-08-05 2005-02-10 Ranbaxy Laboratories Limited Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
US8034823B2 (en) * 2005-02-22 2011-10-11 Savvipharm Inc Method of increasing drug oral bioavailability and compositions of less toxic orotate salts
KR100647068B1 (ko) 2005-09-15 2006-11-23 하나제약 주식회사 라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
DE602007009096D1 (de) * 2006-05-24 2010-10-21 Pfizer Ltd Verfahren zur herstellung von benzopyran-2-olderivaten
EP1862449A1 (en) * 2006-05-31 2007-12-05 Schwarz Pharma Ltd. A shortened synthesis of substituted hydroxymethyl phenols
EA016399B1 (ru) * 2006-05-31 2012-04-30 Шварц Фарма Лтд. Способ синтеза замещенных гидроксиметилфенолов
IES20060424A2 (en) 2006-06-08 2007-10-31 Schwarz Pharma Ltd Accelerated synthesis of (3-Diisopropylamino-1-phenylpropyl)-4-(hydroxymethyl)phenol and its phenolic monoesters
WO2007140986A1 (en) * 2006-06-09 2007-12-13 Schwarz Pharma Ltd Synthesis of phenolic esters of hydroxymethyl phenols
PL2029134T3 (pl) 2006-06-09 2011-12-30 Ucb Pharma Gmbh Stabilizowane kompozycje farmaceutyczne zawierające fezoterodynę
US7807715B2 (en) 2006-06-09 2010-10-05 Ucb Pharma Gmbh Pharmaceutical compositions comprising fesoterodine
AU2007260267B2 (en) * 2006-06-12 2012-09-06 Ucb Pharma Gmbh New chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof
IES20060435A2 (en) 2006-06-12 2007-12-12 Schwarz Pharma Ltd Shortened synthesis using paraformaldehyde or trioxane
US20100217034A1 (en) * 2007-09-21 2010-08-26 Actavis Group Ptc Ehf Process for the Preparation of Fesoterodine
US20100297241A1 (en) * 2007-10-01 2010-11-25 Actavis Group Ptc Ehf Amorphous Fesoterodine Fumarate
EP2294047A2 (en) * 2008-04-04 2011-03-16 Actavis Group PTC EHF Novel mandelate salt of fesoterodine
US20110171274A1 (en) * 2008-07-21 2011-07-14 Actavis Group Ptc Ehf Fesoterodine Substantially Free of Dehydroxy Impurity
IT1392082B1 (it) * 2008-12-10 2012-02-09 Chemi Spa Nuove forme solide della fesoterodina fumarato
ES2533956T3 (es) 2009-05-11 2015-04-16 Ratiopharm Gmbh Desfesoterodina en forma de una sal de ácido tartárico
IT1394217B1 (it) * 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina e/o fesoterodina fumarato.
IT1394219B1 (it) * 2009-05-15 2012-06-01 Chemi Spa Metodo di preparazione di fesoterodina fumarato di elevata purezza.
WO2011029005A1 (en) 2009-09-03 2011-03-10 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Crystalline forms of fesoterodine fumarate and fesoterodine base
IT1396373B1 (it) * 2009-10-29 2012-11-19 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina.
EP2316432A1 (de) 2009-10-30 2011-05-04 ratiopharm GmbH Zusammensetzung enthaltend Fesoterodin und Ballaststoffe
US20110124903A1 (en) * 2009-11-20 2011-05-26 Actavis Group Ptc Ehf Solid state forms of fesoterodine intermediates
IT1397521B1 (it) * 2009-12-21 2013-01-16 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina con un basso contenuto di impurezze.
IT1397920B1 (it) * 2010-02-08 2013-02-04 Dipharma Francis Srl Forma cristallina di fesoterodina fumarato e procedimento per la sua preparazione
US20130172411A1 (en) 2010-03-22 2013-07-04 Cadila Healthcare Limited Stable pharmaceutical compositions comprising fesoterodine
EP2563123B1 (en) 2010-04-30 2018-04-25 Merck Sharp & Dohme Corp. Novel beta 3 adrenergic receptor agonists
WO2011141932A2 (en) 2010-05-11 2011-11-17 Intas Pharmaceuticals Limited Process for preparation of phenolic monoesters of hydroxymethyl phenols
WO2011145019A1 (en) * 2010-05-17 2011-11-24 Orchid Chemicals And Pharmaceuticals Limited Improved process for diphenylpropylamine derivatives
IT1401451B1 (it) 2010-06-10 2013-07-26 Chemi Spa Nuovo processo di preparazione di 2-idrossi-4-fenil-3,4-diidro-2h-cromen-6-il-metanolo e (r)-2-[3-(diisopropilammino)-1-fenilpropil]-4-(idrossimetil)fenolo.
WO2011158257A1 (en) 2010-06-18 2011-12-22 Panacea Biotec Ltd Preparation process of fesoterodine and intermediates
WO2012025941A2 (en) 2010-08-25 2012-03-01 Cadila Healthcare Limited Processes for the preparation of fesoterodine
IT1403094B1 (it) 2010-12-09 2013-10-04 Dipharma Francis Srl Procedimento per la preparazione di fesoterodina o un suo sale
WO2012098560A2 (en) * 2011-01-17 2012-07-26 Msn Laboratories Limited Process for the preparation of muscarinic receptor antagonist
TWI520732B (zh) 2011-01-18 2016-02-11 輝瑞有限公司 固體分子分散液
EP2508175A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Pharmaceutical composition comprising fesoterodine or a salt or a solvate thereof
EP2508173A1 (en) 2011-04-08 2012-10-10 LEK Pharmaceuticals d.d. Stabilized pharmaceutical composition comprising fesoterodine
JP6234999B2 (ja) 2012-05-04 2017-11-22 クリスタル ファルマ、エセ、ア、ウＣｒｙｓｔａｌ Ｐｈａｒｍａ，Ｓ．Ａ．Ｕ． 光学的に活性な３，３−ジフェニルプロピルアミンを調製するための方法
ITMI20121232A1 (it) 2012-07-16 2014-01-17 Cambrex Profarmaco Milano Srl Procedimento per la preparazione di 2-(3-n,n-diisopropilamino-1-fenilpropil)-4-idrossimetil-fenolo e suoi derivati
TR201721437A2 (tr) 2017-12-25 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
EP4237405A1 (en) * 2020-10-27 2023-09-06 Wella Germany GmbH 2-methoxymethyl-p-phenylenediamine in cosmetic grade quality

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA817863B (en) * 1980-11-14 1983-06-29 Lilly Co Eli (-)n-methyl-3-(2-methylphenoxy)-3-phenylpropylamnie,antidepressant
IL66831A0 (en) * 1981-10-05 1982-12-31 Kefalas As Indane derivatives
SE8800207D0 (sv) * 1988-01-22 1988-01-22 Kabivitrum Ab Nya aminer, deras anvendning och framstellning
EP0445749B1 (en) * 1990-03-08 1996-07-10 Fujisawa Pharmaceutical Co., Ltd. N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments
JPH0483431A (ja) * 1990-07-26 1992-03-17 Seiko Epson Corp 選択呼出受信機
SE9203318D0 (sv) 1992-11-06 1992-11-06 Kabi Pharmacia Ab Novel 3,3-diphenylpropylamines, their use and preparation
SE9701144D0 (sv) * 1997-03-27 1997-03-27 Pharmacia & Upjohn Ab Novel compounds, their use and preparation
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE29923134U1 (de) * 1999-11-16 2000-06-29 Sanol Arznei Schwarz Gmbh Stabile Salze neuartiger Derviate von 3,3-Diphenylpropylaminen

Also Published As

Publication number Publication date
EA005588B1 (ru) 2005-04-28
KR100536095B1 (ko) 2005-12-12
DK1481964T3 (da) 2006-11-27
EA200200511A1 (ru) 2002-10-31
MXPA02004603A (es) 2004-09-10
BRPI0015610C1 (pt) 2021-05-25
HK1067114A1 (en) 2005-04-01
WO2001035957A8 (de) 2001-06-21
CZ20021343A3 (cs) 2002-09-11
UA73324C2 (uk) 2005-07-15
BR0015610A (pt) 2002-07-30
NO20065380L (no) 2002-05-15
JP2014111589A (ja) 2014-06-19
JP4083431B2 (ja) 2008-04-30
IL149567A0 (en) 2002-11-10
NO332637B1 (no) 2012-11-26
HK1045148B (zh) 2005-05-06
EP1690536A2 (de) 2006-08-16
DE50015163D1 (de) 2008-06-26
AU2666701A (en) 2001-05-30
HU228197B1 (en) 2013-01-28
JP2010180242A (ja) 2010-08-19
SI1481964T1 (sl) 2006-12-31
CZ302967B6 (cs) 2012-01-25
JP5290351B2 (ja) 2013-09-18
JP5717824B2 (ja) 2015-05-13
CA2389749C (en) 2009-03-31
US6858650B1 (en) 2005-02-22
ES2236032T3 (es) 2005-07-16
HUP0204034A2 (hu) 2003-03-28
AU778132B2 (en) 2004-11-18
ES2270240T3 (es) 2007-04-01
JP2007137895A (ja) 2007-06-07
UA77322C2 (en) 2006-11-15
CA2389749A1 (en) 2001-05-25
ES2303708T3 (es) 2008-08-16
HUP0204034A3 (en) 2004-12-28
EP1481964B1 (de) 2006-08-23
SI1230209T1 (en) 2005-06-30
SI1690536T1 (sl) 2008-08-31
ATE286872T1 (de) 2005-01-15
EP1481964A1 (de) 2004-12-01
DE19955190A1 (de) 2001-06-21
ES2236032T7 (es) 2012-06-14
PT1481964E (pt) 2006-12-29
SK6572002A3 (en) 2002-12-03
EP1690536B1 (de) 2008-05-14
SK288185B6 (sk) 2014-04-02
CY1106204T1 (el) 2011-06-08
NO20022314L (no) 2002-05-15
IS2124B (is) 2006-07-14
CZ302497B6 (cs) 2011-06-15
WO2001035957A3 (de) 2001-12-27
HK1095736A1 (en) 2007-05-18
DE29923134U1 (de) 2000-06-29
JP5650924B2 (ja) 2015-01-07
JP2010180243A (ja) 2010-08-19
PL356766A1 (en) 2004-07-12
SK288384B6 (sk) 2016-08-01
HK1045148A1 (en) 2002-11-15
EP1230209B1 (de) 2005-01-12
EP1690536A3 (de) 2006-08-23
IS8382A (is) 2006-03-29
CN1390194A (zh) 2003-01-08
JP2011148824A (ja) 2011-08-04
BRPI0015610B1 (pt) 2016-04-19
WO2001035957A1 (de) 2001-05-25
DE50013365D1 (de) 2006-10-05
IS6351A (is) 2002-04-19
ATE395056T1 (de) 2008-05-15
DK1690536T3 (da) 2008-09-01
EP1230209B3 (de) 2011-10-05
PT1690536E (pt) 2008-07-14
KR20020059744A (ko) 2002-07-13
CY1110389T1 (el) 2015-04-29
HU0900587D0 (en) 2009-11-30
NO20022314D0 (no) 2002-05-15
JP2003514018A (ja) 2003-04-15
ATE337293T1 (de) 2006-09-15
CN1215045C (zh) 2005-08-17
EP1230209A2 (de) 2002-08-14
JP5503393B2 (ja) 2014-05-28
GEP20084430B (pt) 2008-07-25
KR20050100711A (ko) 2005-10-19
SK287430B6 (sk) 2010-09-07
DE50009239D1 (de) 2005-02-17
PT1230209E (pt) 2005-05-31
IL149567A (en) 2007-08-19
DK1230209T3 (da) 2005-05-30
HUP0900587A3 (en) 2010-04-28
ZA200203315B (en) 2003-09-23
IS2673B (is) 2010-09-15
KR100563149B1 (ko) 2006-03-21
PL201422B1 (pl) 2009-04-30
NO323920B1 (no) 2007-07-23
NZ519230A (en) 2004-11-26
HU227608B1 (en) 2011-09-28

Similar Documents

Publication Publication Date Title
BR0015610B8 (pt) composto derivado de 3,3-difenilpropilamina, processo para preparação do mesmo, utilização de intermediários na obtenção do referido composto
DOP2002000512A (es) Sales de acido succinato de 5,7,14-triazatetraciclo [10.3.1.0² ¹¹.04,9] hexadeca-2 (11),3,5,7,9-pentaeno y composiciones farmaceuticas de las mismas
BR9910921A (pt) Composto, processo para preparar o mesmo, formulação farmacêutica, uso de um composto, e, processo para a profilaxia e/ou tratamento de condições clìnicas associadas com a resistência à insulina
BRPI0514448A (pt) derivados do ácido bifenil-oxiacético para uso no tratamento de doenças respiratórias
PT90803A (pt) Processo para a preparacao de novos derivados de pirimidina
AR082581A2 (es) Procedimientos de preparacion de combretastatinas
BR0313831A (pt) Sais benzenossulfonato de derivados de 4-flúor-2-cianopirrolidina
BRPI0409105A (pt) análogos de quinobenzoxazina substituìdos
BR0211691A (pt) Processo para a prepara de tolterodina
BR0315995A (pt) Composto, uso de um composto composição farmacêutica, métodos para a terapia da dor, de distúrbios gastrointestinais, e da ansiedade em um animal de sangue quente, e, processo para preparar um composto
BR0104471A (pt) Compostos de ciclobutenodiona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos
BRPI0414554A (pt) compostos e seus usos em medicina: processo para preparação destes e composições farmacêuticas que os contenham
PT937043E (pt) Novos derivados tetra-hidropiridinicos substituidos processo para a sua preparacao e as composicoes farmaceuticas que os contem
ES2383714T3 (es) Proceso para preparar un compuesto (S)-1-alquil-2',6'-pipecoloxilidídico
AR023900A1 (es) (1R, 2S, 4R) - (-)-2-[(2'-{N,N-DIMETILAMINO}-ETOXI)/-2-/FENIL/-1, 7, 7-TRI -/METIL/-BICICLO/2.2.1/HEPTANO DE ALTA PUREZA Y LAS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES DEL MISMO, ASI COMO UN PROCESO PARA LA PREPARACIoN DE ESTOS COMPUESTOS Y MEDICAMENTOS QUE CONTIENEN UNO O MAS DE ESTOS
BR0015877A (pt) Polimorfo v de torasemida
ES2068624T3 (es) Procedimiento para la preparacion de l-carnitina a partir de sales d,l-carnitinonitrilo.
FR2892721B1 (fr) Nouveau procede de preparation de sels d'acides et d'ammonium quaternaires
BR8700191A (pt) Derivados de 2-alquilbenzimidazol,compostos,processo para a preparacao dos mesmos,composicoes farmaceuticas e utilizacao dos derivados
MX9400200A (es) Derivados de acido nonatetraenoico, proceso para su preparacion y composicion farmaceutica que los contiene.
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
AR034583A1 (es) Compuestos de isoindoloindolona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
AR046212A1 (es) Derivados de 2-fenilbenzofurano, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
BR0012493B1 (pt) processo para a preparação de um composto de éster de ácido 2-hidróxi-benzóico substituìdo, e, processo para a manufatura de composto fungicida de benzofenona.
BR0312452A (pt) Composto; processo para a preparação de um composto; composição farmacêutica; uso de um composto; e método para o tratamento e/ou profilaxia de doenças que são moduladas por agonistas de ppar(alfa) e/ou ppar(gama)

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8O E 13 DA LPI.

B12B Appeal against refusal [chapter 12.2 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI.

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/04/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/11/2000 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 15/11/2020